Rapport Therapeutics Inc.... (RAPP)
8.64
-0.34 (-3.79%)
At close: Apr 10, 2025, 3:59 PM
8.63
-0.17%
After-hours: Apr 10, 2025, 04:05 PM EDT
Rapport Therapeutics Common Stock Revenue
Rapport Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Rapport Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
69
Market Cap
315.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |